Skip to main content
Noma survivors: closer to getting the attention they deserve

Neglected diseases

Neglected diseases disproportionally affect people in the world’s least-developed countries and there are few tools available with which to diagnose and treat.

They cover neglected tropical diseases, such as kala azar (visceral leishmaniasis) and sleeping sickness (human African trypanosomiasis), plus issues such as snakebite envenoming, but also Chagas, noma, cutaneous leishmaniasis, and others.

These diseases are considered ‘neglected’, as – although they are usually life-threatening and claim thousands of lives every year – the pharmaceutical and diagnostic industries ignore the development of vaccines, diagnostic tools and drugs to tackle them.

Neglected diseases

 
Journal article

Clinical Epidemiology, Diagnosis and Treatment of Visceral Leishmaniasis in the Pokot Endemic Area of Uganda and Kenya

8 Jan 2014
Journal article
 
Journal article

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

2 Jan 2014
Journal article
 
Journal article

The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment

24 Oct 2013
Journal article
 
Access to medicines

DNDi at ten: past success, future challenges

Campaign 16 May 2013
 
MSF Chagas project in Aiquile, Bolivia
Project Update

We are in a historic momentum to transform the lives of millions of people

Voices from the Field 16 Apr 2013
 
Photo Story
27 Feb 2013
Photo Story
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site